Breast cancer care compared with clinical Guidelines: an observational study in France

被引:18
|
作者
Lebeau, Marie [2 ]
Mathoulin-Pelissier, Simone [1 ,3 ,4 ,5 ]
Bellera, Carine [3 ,4 ]
Tunon-de-Lara, Christine [6 ]
Daban, Alain [2 ]
Lipinski, Francis [7 ]
Jaubert, Dominique [1 ]
Ingrand, Pierre [2 ]
Migeot, Virginie [2 ]
机构
[1] Reseau Cancerol Aquitaine, F-33076 Bordeaux, France
[2] CHU Poitiers, Serv Radiotherapie, Poitiers, France
[3] CRLCC Inst Bergonie, Unite Rech & Epidemiol Clin, F-33076 Bordeaux, France
[4] INSERM, CIC EC7, F-33076 Bordeaux, France
[5] Univ Victor Segalen Bordeaux 2, F-33076 Bordeaux, France
[6] CRLCC Inst Bergonie, Serv Chirurg, F-33076 Bordeaux, France
[7] Ctr Oncoradiotherapie Cote Basque, Bayonne, France
关键词
STAGE; QUALITY; WOMEN; IMPLEMENTATION; RADIOTHERAPY; MANAGEMENT; CARCINOMA;
D O I
10.1186/1471-2458-11-45
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Great variability in breast cancer (BC) treatment practices according to patient, tumour or organisation of care characteristics has been reported but the relation between these factors is not well known. In two French regions, we measured compliance with Clinical Practice Guidelines for non-metastatic BC care management and identified factors associated with non-compliance at clinical and organisational levels. Methods: Eligible patients had invasive unilateral BC without distant metastases and at least two contacts with one of the two regional healthcare systems (2003-2004) in the first year after diagnosis. Medical data were collected from patient medical records in all public and private hospitals (99 hospitals). The care process was defined by 20 criteria: clinical decisions for treatment and therapeutic procedures. Each criterion was classified according to level of compliance ("Compliant", "Justifiable" and "Not Compliant") and factors of non-compliance were identified (mixed effect logistic regression). Results: 926 women were included. Non-compliance with clinical decisions for treatment was associated with older patient age (OR 2.1; 95%CI: 1.3-3.6) and region (OR 3.0; 95%CI: 1.2-7.4). Non-compliance with clinical decisions for radiotherapy was associated with lymph node involvement or the presence of peritumoural vascular invasion (OR 1.5; 95%CI: 1.01-2.3) and non-compliance with overall treatment (clinical decisions for treatment + therapeutic procedures) was associated with the presence of positive lymph nodes (OR 2.0; 95%CI: 1.2-3.3), grade III versus grade I (OR 2.9; 95%CI: 1.4-6.2), and one region of care versus another (OR 3.5; 95%CI: 1.7-7.1). Finally, heterogeneity of compliance in overall treatment sequence was identified between local cancer units (p < 0.05). Conclusion: This study provides interesting insights into factors of non-compliance in non-metastatic BC management and could lead to quality care improvements.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Observational study of clinical toxicity with different formulations of docetaxel in breast cancer patients
    Gonzalez-Haba-Pena, Eva
    Garrido-Siles, Margarita
    Jose Martinez-Bautista, Maria
    Burgos-San Jose, Amparo
    Aldaz-Pastor, Azucena
    Mangues-Bafalluy, Irene
    FARMACIA HOSPITALARIA, 2020, 44 (05) : 192 - 197
  • [22] Clinical practice guidelines for the care and treatment of breast cancer: the management of chronic pain in patients with breast cancer (summary of the 2001 update)
    Emery, C
    Gallagher, R
    Hugi, M
    Levine, M
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2001, 165 (09) : 1218 - 1219
  • [23] Clinical practice guidelines for cancer care: what are they for?
    Paula Manchon Walsh
    Josep M. Borràs
    Clinical and Translational Oncology, 2009, 11 : 775 - 776
  • [24] Clinical practice guidelines for cancer care: what are they for?
    Manchon Walsh, Paula
    Borras, Josep M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (12): : 775 - 776
  • [25] Clinical Guidelines for the Care of Childhood Cancer Survivors
    Tonorezos, Emily S.
    Henderson, Tara O.
    CHILDREN-BASEL, 2014, 1 (02): : 227 - 240
  • [26] Breast cancer in Western Australia: clinical practice and clinical guidelines
    McEvoy, SP
    Ingram, DM
    Byrne, MJ
    Joseph, DJ
    Dewar, J
    Trotter, J
    Harper, C
    Haworth, C
    Harvey, JM
    Sterrett, GF
    Jamrozik, K
    Fritschi, L
    MEDICAL JOURNAL OF AUSTRALIA, 2004, 181 (06) : 305 - +
  • [27] A COST-EFFECTIVENESS ANA LYSIS OF A GENOMIC TEST COMPARED TO STANDARD OF CARE IN BREAST CANCER PATIENTS IN FRANCE
    Dorey, J.
    Disset, A.
    Neine, Elmoctar M.
    Plun-Favreau, J.
    Toumi, M.
    VALUE IN HEALTH, 2015, 18 (07) : A457 - A457
  • [28] Attributes of clinical guidelines that influence use of guidelines in general practice: observational study
    Grol, R
    Dalhuijsen, J
    Thomas, S
    in't Veld, C
    Rutten, G
    Mokkink, H
    BRITISH MEDICAL JOURNAL, 1998, 317 (7162): : 858 - 861
  • [29] Care guidelines for young women diagnosed with breast cancer
    DeCoteau, M. J.
    CANCER RESEARCH, 2016, 76
  • [30] Building Consensus Around The Use of Clinical Practice Guidelines for Breast and Colon Cancer Survivorship Care
    Tofani, Barbara
    Johansen, Mary
    NURSING RESEARCH, 2018, 67 (02) : E123 - E124